We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Formation of Adipose Scar Tissue Begins with Activation of Platelet-Derived Growth Factor Receptor Alpha Signaling

By LabMedica International staff writers
Posted on 08 Jun 2015
Researchers have found a link between activation of PDGFRalpha (platelet-derived growth factor receptor alpha) signaling in perivascular cells (such as pericytes, connective tissue cells that occur about small blood vessels) and the formation of scar tissue that can lead to metabolic dysfunction and development of chronic diseases such as diabetes.

Fibrosis is a common disease process in which pro-fibrotic cells disturb organ function by secreting disorganized extracellular matrix (ECM). More...
Adipose tissue fibrosis occurs during obesity and is associated with metabolic dysfunction, but how pro-fibrotic cells originate is as yet unknown.

In this regard, investigators at Oklahoma Medical Research Foundation (Oklahoma City, USA) used a developmental model to investigate perivascular cells in white adipose tissue (WAT) and their potential to cause organ fibrosis.

They reported in the May 27, 2015, online edition of the journal Genes & Development that activation of PDGFRalpha signaling in perivascular cells caused them to transition into ECM-synthesizing pro-fibrotic cells. Before this transition occurred, PDGFRalpha signaling up-regulated mTOR (mammalian target of rapamycin) signaling and ribosome biogenesis pathways and perturbed the expression of a network of epigenetically imprinted genes that had been implicated in cell growth and tissue homeostasis.

"Scarring can be an important part of the healing process when a person suffers an injury," said senior author Dr. Lorin Olson, assistant professor of immunobiology and cancer research at Oklahoma Medical Research Foundation. "But excessive scarring, or fibrosis, can contribute to many dangerous health conditions. When fat cells are surrounded by scar tissue, it inhibits their ability to store lipids. When that happens, the lipids are stored in places like the liver or muscle. That can cause insulin resistance, which can lead to diabetes. By studying the molecular mechanisms involved in the process, we will try to understand the role it may play in heart disease, diabetes and other metabolic disorders."

Related Links:

Oklahoma Medical Research Foundation



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.